Connor, EM, Sperling, RS, Gelber, R, et. al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331(18):1173–1180.CrossRefGoogle Scholar

Townsend, CL, Byrne, L, Cortina-Borja, M, et al. Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011. AIDS. 2014;28(7):1049–1057.CrossRefGoogle ScholarPubMed

Forbes, JC, Alimenti, AM, Singer, J, et al. A national review of vertical HIV transmission. AIDS. 2012;26(6):757–763.Google Scholar

Ioannidis, JP, Contopoulos-Ioannidis, DG. Maternal viral load and the risk of perinatal transmission of HIV-1. N Engl J Med. 1999 Nov 25;341(22):1698–1700.Google Scholar

Panel on treatment of HIV-infected pregnant women and prevention of perinatal transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf. Accessed March 19, 2016.Google Scholar

Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data – United States and 6 dependent areas, 2012. HIV Surveillance Supplemental Report 2014;19(3). www.cdc.gov/hiv/library/repors/surveillance/. Published November 2014. Accessed February 27, 2016.Google Scholar

Skarbinski, J, Rosenberg, E, Paz-Bailey, G, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015;175:588–596.Google Scholar

Centers for Disease Control and Prevention. HIV Among Women, Infants, and Children. Available at www.cdc.gov/hiv/group/gender/pregnantwomen/. Page updated June 15, 2015. Accessed March 19, 2016.Google Scholar

Centers for Disease Control and Prevention. Reduction in perinatal transmission of HIV infection – United States, 1985–2005. MMWR 2006;55:592–597.Google Scholar

Branson, BM, Handsfield, HH, Lampe, MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Sept 22, 2006;55(RR14);1–17.Google Scholar

ACOG Committee Opinion No 635. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. American College of Obtetricians and Gynecologists. Obstet Gynecol. 2015 Jun;125(6):1544–1547.Google Scholar

Centers for Disease Control and Prevention and Association of Public Health Laboratories. Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations. Available at http://stacks.cdc.gov/view/cdc/23447. Published June 27, 2014. Accessed February 20, 2016.Google Scholar

Vogler, MA, Patterson, K, Kamemoto, L, et al. Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188. J Acquire Immune Defic Syndr. 2010;55(4):437–82.Google ScholarPubMed

Stringer, EM, Kaseba, C, Levy, J, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol 2007;197:144.e1–144.e8.Google Scholar

Robinson, JA, Jamshidi, R, Burke, AE. Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy. Infect Dis Obstet Gynecol. 2012;2012:890160. doi:10.1155/2012/890160. Available at www.hindawi.com/journals/idog/2012/890160/Google Scholar

Landolt, NK, Phanuphak, N, Ubolyam, S, et al. Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIV-positive women. J Acquir Immune Defic Syndr. 2014;66(2):e50–e52. Available at www.ncbi.nlm.nih.gov/pubmed/24608892.Google Scholar

Perry, SH, Swamy, P, Preidis, GA, Mwanyumba, A, Motsa, N, Sarero, HN. Implementing the Jadelle implant for women living with HIV in a resource-limited setting in sub-Saharan Africa: concerns for drug interactions leading to unintended pregnancies. AIDS. 2014. Available at www.ncbi.nlm.nih.gov/pubmed/24401645.Google Scholar

Morrison, CS, Sekadde-Kigondu, C, Sinei, SK, Weiner, DH, Kwok, C, Kokonya, D. Is the intrauterine device appropriate contraception for HIV-1-infected women?. BJOG. 2001;108: 784–790.Google Scholar

ACOG Committee Opinion No 313. The importance of preconception care in the continuum of women’s healthcare. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2005 Sep;106(3):665–666.Google Scholar

Lampe, MA, Smith, DK, Anderson, GJE, et al. Achieving safe conception in HIV-discordant couples: the potential role of oral preexposure prophylaxis (PrEP) in the United States. Am J Obstet Gynecol 2011;204:488.e1–8.CrossRefGoogle ScholarPubMed

Matthews, L, Smit, J, Cu-Uvin, S, Cohan, D. Antiretrovirals and safer conception for HIV-serodiscordant couples. Curr Opin HIV AIDS. 2012, 7:569–578.Google Scholar

Ethics Committee of the American Society for Reproductive M. Human immunodeficiency virus and infertility treatment. Fertil Steril. 2010;94(1):11–15.Google Scholar

Semprini, AE, Macaluso, M, Hollander, L, et al. Safe conception for HIV-discordant couples: Insemination with processed semen from the HIV-infected partner. Am J Obstet Gynecol. 2013 May;208(5):402.e1–9.CrossRefGoogle ScholarPubMed

Vernazza, PL, Graf, I, Sonnenberg-Schwan, U, et al. Preexposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child. AIDS. 2011;25(16):2005–2008.Google Scholar

CDC. Preexposure prophylaxis for the prevention of HIV infection in the United States-2014. www.cdc.gov/hiv/pdf/prepguidelines2014.pdf. Accessed March 19, 2016.Google Scholar

Garcia, PM, Kalish, LA, Pitt, J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med. 1999;341(6):394–402.CrossRefGoogle ScholarPubMed

Cooper, ER, Charurat, M, Mofenson, L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29:484–494.Google Scholar

Jourdain, G, Mary, JY, Coeur, SL, Ngo-Giang-Huong, N, Yuthavisuthi, P, Limtrakul, A, et al. Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand. J Infect Dis. 2007;196(11):1629–1636.Google Scholar

Whitmore, SK, Taylor, AW, Espinoza, L, Shouse, RL, Lampe, MA, Nesheim, S. Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico. Pediatrics. 2012;129;e74–e81.Google Scholar

Drake, AL, Wagner, A, Richardson, B, John-Stewart, G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: A systematic review and meta-analysis. PLoS Med Feb 2014;11(2):e1001608. doi:10.1371/journal.pmed.1001608.Google Scholar

Burns, DN, Landesman, S, Muenz, LR, et al. Cigarette smoking, premature rupture of membranes and vertical transmission of HIV-1 among women with low CD4 levels. J Acquir Immune Defic Syndr Hum Retrovirol. 1994;7(7):718–726.Google Scholar

Turner, BJ, Hauck, WW, Fanning, TR, Markson, LE. Cigarette smoking and maternal–child HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14(4):327–337.Google Scholar

Rodriguez, EM, Mofenson, LM, Chang, BH, et al. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS. 1996;10(3):273–282.Google Scholar

Bulterys, M, Landesman, S, Burns, DN, et al. Sexual behavior and injection drug use during pregnancy and vertical transmission of HIV-1. J Acquir Immune Defic Syndr Human Retrovirol. 1997;15(1):76–82.Google Scholar

Matheson, PB, Thomas, PA, Abrams, EJ, et al. New York City Perinatal HIV Transmission Collaborative Study Group. Heterosexual behavior during pregnancy and perinatal transmission of HIV-1. AIDS. 1996;10(11):1249–1256.Google Scholar

Read, PJ, Mandalia, S, Khan, P, et al. When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery? AIDS. 2012;26(9):1095–1103.Google Scholar

Tubiana, R, Le Chenadec, J, Rouzioux, C, et al. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: A case–control study nested in the French perinatal cohort (EPF-ANRS CO1). Clin Infect Dis. 2010;50(4):585–596.Google Scholar

Ford, N, Mofenson, L, Shubber, Z, et al. Safety of efavirenz in the first trimester of pregnancy: An updated systematic review and meta-analysis. AIDS. 2014;28 Suppl 2:S123–S131.Google Scholar

Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed March 19, 2016.Google Scholar

Aziz, N, Sokoloff, A, Kornak, J, et al. Time to viral load suppression in antiretroviral-naive and -experienced HIV infected pregnant women on highly active antiretroviral therapy: Implications for pregnant women presenting late in gestation. BJOG 2013;120(12):1534–1547.Google Scholar

Wong, VV. Is peripartum zidovudine absolutely necessary for patients with a viral load less than 1,000 copies/ml? J Obstet Gynaecol. 2011;31(8):740–742.Google Scholar

Briand, N, Warszawski, J, Mandelbrot, L, et al. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era? Clin Infect Dis. 2013;57(6):903–914.Google Scholar

Cotter, AM, Brookfield, KF, Duthely, LM, Gonzalez Quintero, VH, Potter, JE, O’Sullivan, MJ. Duration of membrane rupture and risk of perinatal transmission of HIV-1 in the era of combination antiretroviral therapy. Am J Obstet Gynecol. 2012;207(6):482 e481–485.Google Scholar